ADAMTS9

ADAM metallopeptidase with thrombospondin type 1 motif 9, the group of ADAM metallopeptidases with thrombospondin type 1 motif

Basic information

Region (hg38): 3:64515654-64688000

Links

ENSG00000163638NCBI:56999OMIM:605421HGNC:13202Uniprot:Q9P2N4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • nephronophthisis 1 (Supportive), mode of inheritance: AR
  • ciliopathy (Limited), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ADAMTS9 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS9 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
38
clinvar
14
clinvar
52
missense
151
clinvar
10
clinvar
11
clinvar
172
nonsense
2
clinvar
2
start loss
0
frameshift
1
clinvar
1
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
5
2
7
non coding
14
clinvar
81
clinvar
95
Total 0 0 157 62 106

Variants in ADAMTS9

This is a list of pathogenic ClinVar variants found in the ADAMTS9 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-64522181-C-T ADAMTS9-related disorder Benign (Jan 25, 2024)1294798
3-64522185-C-T not specified Uncertain significance (Mar 20, 2024)3268028
3-64522197-T-G Uncertain significance (Sep 22, 2022)2031785
3-64522219-T-C Benign (Dec 07, 2023)791933
3-64522237-T-C ADAMTS9-related disorder Benign (Jan 01, 2024)789164
3-64522245-C-T ADAMTS9-related disorder Likely benign (Oct 27, 2023)1546394
3-64522250-C-T not specified Uncertain significance (Apr 18, 2023)2566590
3-64532946-G-A Benign (May 24, 2021)1227721
3-64533147-C-T Likely benign (Aug 10, 2023)1556219
3-64533167-G-A not specified Uncertain significance (Sep 17, 2021)2364593
3-64533193-A-G Likely benign (Jul 12, 2023)2980270
3-64533203-T-C not specified Uncertain significance (Jun 02, 2023)2525903
3-64533226-A-G Likely benign (Nov 27, 2023)1910792
3-64533238-G-C Likely benign (Mar 08, 2023)2712811
3-64533252-G-C not specified Uncertain significance (Sep 13, 2023)2623046
3-64533267-G-T not specified Uncertain significance (Sep 01, 2021)2228657
3-64533318-T-C Benign (May 08, 2021)1265324
3-64533480-C-T Benign (May 08, 2021)1232527
3-64539229-A-G not specified Uncertain significance (Jun 02, 2024)3268071
3-64539232-C-A Uncertain significance (Aug 10, 2023)1410113
3-64539236-G-A Likely benign (Sep 07, 2022)2143033
3-64539265-C-T not specified Uncertain significance (Jul 26, 2021)2228501
3-64540891-A-G Benign (May 10, 2021)1245807
3-64540934-G-A Benign (May 08, 2021)1228118
3-64540936-T-C Benign (May 10, 2021)1251849

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ADAMTS9protein_codingprotein_codingENST00000498707 39172344
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000001001.001256680801257480.000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.95510301.12e+30.9200.000063412696
Missense in Polyphen240402.70.595984536
Synonymous-3.094954151.190.00002453598
Loss of Function7.13351190.2940.000006571327

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007360.000736
Ashkenazi Jewish0.00009930.0000992
East Asian0.0003310.000326
Finnish0.0001850.000185
European (Non-Finnish)0.0002970.000281
Middle Eastern0.0003310.000326
South Asian0.0005050.000490
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cleaves the large aggregating proteoglycans, aggrecan (at the '1838-Glu-|-Ala-1839' site) and versican (at the '1428- Glu-|-Ala-1429' site). Has a protease-independent function in promoting the transport from the endoplasmic reticulum to the Golgi apparatus of a variety of secretory cargos. {ECO:0000269|PubMed:12514189, ECO:0000269|PubMed:22419820}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Degradation of the extracellular matrix;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation (Consensus)

Intolerance Scores

loftool
0.651
rvis_EVS
-2.39
rvis_percentile_EVS
1.08

Haploinsufficiency Scores

pHI
0.198
hipred
N
hipred_score
0.427
ghis
0.495

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.352

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Adamts9
Phenotype
embryo phenotype; pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; cellular phenotype; immune system phenotype; endocrine/exocrine gland phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
adamts9
Affected structure
pancreatic B cell
Phenotype tag
abnormal
Phenotype quality
decreased area

Gene ontology

Biological process
heart valve morphogenesis;ventricular cardiac muscle tissue development;proteolysis;glycoprotein catabolic process;multicellular organism development;response to bacterium;negative regulation of endothelial cell migration;protein transport;vesicle-mediated transport;extracellular matrix organization;aorta morphogenesis;positive regulation of melanocyte differentiation;endothelial cell-matrix adhesion;negative regulation of sprouting angiogenesis
Cellular component
extracellular space;endoplasmic reticulum;cell surface;extracellular matrix;intracellular membrane-bounded organelle;collagen-containing extracellular matrix
Molecular function
metalloendopeptidase activity;metallopeptidase activity;zinc ion binding